Market Outlook
The US Transcatheter Heart Valve Devices Market was valued at approximately USD 6.18 billion in 2025, with historical analysis conducted from 2021 to 2024. The market is projected to reach nearly USD 16.94 billion by 2035, expanding at a CAGR of 10.62% during the forecast period 2026–2035.
Transcatheter heart valve therapies have revolutionized structural heart treatment in the United States. Over the last decade, transcatheter aortic valve replacement (TAVR) has transitioned from a high-risk patient solution to a frontline therapy for low-risk surgical candidates. Today, annual TAVR procedures in the US exceed 100,000 cases, surpassing surgical aortic valve replacement volumes.
The US healthcare system, supported by strong Medicare reimbursement frameworks and FDA regulatory pathways, remains the global leader in transcatheter valve adoption. Aging demographics, growing prevalence of valvular heart diseases, and increasing patient preference for minimally invasive procedures are primary contributors to sustained growth.
As technology advances toward next-generation valve durability, lower-profile delivery systems, and expanded mitral and tricuspid indications, the US transcatheter valve landscape is expected to witness robust expansion through 2035.
Introduction
According to the US Transcatheter Heart Valve Devices Market Report, this sector reflects the rapid clinical transition from open-heart surgery to catheter-based structural heart interventions. Valvular heart disease affects over 5 million Americans annually, with aortic stenosis and mitral regurgitation representing the most common conditions.
Traditional surgical valve replacement, though effective, involves sternotomy and cardiopulmonary bypass, limiting eligibility for elderly or high-risk patients. Transcatheter therapies allow percutaneous valve implantation via femoral or alternative access routes, significantly reducing recovery time and hospital stay.
The United States leads in procedural innovation, clinical trial activity, and early commercialization of next-generation transcatheter valves. Academic institutions, cardiovascular centers of excellence, and industry partnerships drive continuous innovation.
Key Market Drivers: What’s Fueling the US Transcatheter Heart Valve Devices Market Growth?
- Aging Population and Degenerative Valve Disease
More than 54 million Americans are aged 65 and older, a demographic highly susceptible to degenerative aortic stenosis and mitral regurgitation. As life expectancy increases, the demand for minimally invasive valve therapies continues to grow. - Expansion of FDA Indications
The FDA’s expansion of TAVR to low-risk surgical candidates dramatically increased the addressable patient population. Similar expansions in mitral and tricuspid indications are expected to further boost procedural volumes. - Favorable CMS Reimbursement
CMS national coverage determinations for TAVR and LAA procedures support widespread hospital adoption. Medicare reimbursement ensures financial viability for structural heart programs across the US. - Technological Advancements
Innovations such as repositionable valves, improved leaflet durability, and smaller sheath sizes enhance safety and procedural efficiency. Imaging integration and AI-assisted procedural planning improve outcomes. - Shift Toward Minimally Invasive Care
Patients increasingly prefer shorter recovery times and reduced hospital stays, accelerating transcatheter adoption over open surgery.
Innovation in Focus: Advancements Shaping the Market
Manufacturers are investing heavily in next-generation transcatheter valve platforms designed for durability beyond 10–15 years. Innovations in tissue engineering, anti-calcification treatments, and hemodynamic optimization improve long-term outcomes.
Mitral and tricuspid transcatheter repair technologies represent the next frontier. Clinical trials across US cardiac centers are evaluating transcatheter tricuspid valve replacement systems, potentially unlocking a large untreated population.
Hybrid operating rooms, advanced echocardiography, and real-time 3D imaging further enhance procedural precision.
Recent Developments
Recent FDA approvals for expanded TAVR indications, ongoing mitral and tricuspid valve trials, and increased adoption of next-generation valve platforms highlight dynamic market activity. Hybrid OR investments and digital procedural planning platforms further support growth.
Conclusion
The US Transcatheter Heart Valve Devices Market Size & Share continues to expand as minimally invasive therapies replace surgical approaches. Supported by aging demographics, reimbursement stability, and technological innovation, the market is positioned for sustained double-digit growth through 2035. The US remains the global epicenter for transcatheter valve innovation and adoption.
Key Market Players
The US Transcatheter Heart Valve Devices Competitive Landscape is moderately consolidated. Key players include:
- Edwards Lifesciences
- Medtronic
- Abbott Laboratories
- Boston Scientific
- JenaValve Technology
- MicroPort Scientific
- Venus MedTech
- Lepu Medical
- Meril Life Sciences
- HighLife SAS
- Cardiovalve
- NeoChord
- Ancora Heart
- Corcym
- W. L. Gore & Associates
- Cook Medical
- Terumo Corporation
- Biotronik
- Artivion
- CryoLife
- AtriCure
- LivaNova
- Peijia Medical
- Bracco Imaging (procedural imaging support)
- Siemens Healthineers (imaging integration)
- Transcatheter Aortic Valve Replacement (TAVR) Devices – Dominant Segment
TAVR represents over 70% of total revenue. Adoption spans high-, intermediate-, and low-risk surgical populations. Continuous device improvements support sustained dominance. - Transcatheter Mitral Valve Repair (TMVR) Devices
Edge-to-edge repair systems drive growth. Increasing mitral regurgitation prevalence fuels demand. - Transcatheter Mitral Valve Replacement Devices
Emerging segment with ongoing clinical trials across major US heart centers. - Transcatheter Tricuspid Valve Repair & Replacement Devices – Fastest Growing
Expanding recognition of tricuspid regurgitation as a significant unmet clinical need drives innovation.
- Aortic Stenosis – Largest Segment
High prevalence among elderly Americans ensures continued TAVR demand. - Mitral Regurgitation
Increasing diagnosis rates and improved imaging techniques expand patient eligibility. - Tricuspid Regurgitation
Previously underdiagnosed condition gaining clinical attention. - Structural Valve Degeneration
Growing need for valve-in-valve procedures as earlier implants age.
- Hospitals – Dominant
Large tertiary care hospitals conduct the majority of TAVR and TMVR procedures. - Cardiac Catheterization Laboratories
Increasing role in minimally invasive interventions. - Ambulatory Surgical Centers – Emerging
Selective structural interventions gradually shifting toward outpatient models. - Specialty Heart Institutes
High-volume structural heart programs driving innovation and research.
- Transfemoral – Preferred Route
Accounts for majority of procedures due to reduced invasiveness. - Transapical
Used in patients unsuitable for femoral access. - Transaortic
Alternative route for complex anatomies. - Transcarotid & Others
Expanding usage in select patient populations.
West Region – Market Leader
California leads the US in TAVR volumes due to extensive hospital networks and aging populations. Los Angeles, San Francisco, and San Diego house multiple high-volume structural heart centers.
Washington benefits from strong research institutions in Seattle. Colorado and Arizona show high adoption driven by retiree populations. Oregon and states including Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are expanding structural heart programs supported by CMS reimbursement.
Northeast – Innovation & Academic Excellence
New York and Massachusetts host leading academic hospitals conducting advanced clinical trials. New Jersey and Pennsylvania demonstrate high procedural density. Connecticut and smaller states including Maine, Vermont, New Hampshire, Rhode Island, and Delaware rely on referral networks to regional cardiac hubs.
South – Fastest Growing Region
Texas and Florida represent major growth engines due to large aging populations. Georgia and North Carolina are expanding structural heart programs rapidly. Tennessee, South Carolina, Alabama, and others including Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Maryland, Virginia, and West Virginia are increasing TAVR capacity through hospital modernization initiatives.
Midwest – Steady Expansion
Illinois and Ohio lead procedural volumes. Michigan and Minnesota host reputable heart institutes. Indiana, Wisconsin, Missouri, and others including Iowa, Kansas, Nebraska, North Dakota, and South Dakota demonstrate steady adoption supported by Medicare coverage and improved access.
1. US Transcatheter Heart Valve Devices Market: Market Introduction & Context
1.1 Market Definition
1.2 Scope of the Study
1.3 Research Methodology
1.3.1 Primary Data Collection
1.3.2 Secondary Data Sourcing
1.3.3 External Industry Collaborations
1.3.4 In-House Research Databases
1.3.5 Analytical Frameworks & Forecasting Models
1.3.6 Data Validation and Final Report Publishing
1.4 Key Assumptions
1.5 Market Ecosystem Overview
1.6 Stakeholder Analysis (Device Manufacturers, Component Suppliers, Hospitals, Cardiac Centers, Regulatory Authorities, Payers)
(What this section provides: Introduces the scope, research framework, ecosystem participants, and core assumptions underpinning the US Transcatheter Heart Valve Devices Market analysis.)
2. US Transcatheter Heart Valve Devices Market: Executive Summary
2.1 Key Insights & Market Snapshots
2.2 Analyst Viewpoint
2.3 Market Attractiveness Index
(What this section provides: Highlights key growth trends, revenue outlook (2022–2035), leading segments, and competitive positioning within the US market.)
3. US Transcatheter Heart Valve Devices Market: Market Dynamics & Outlook
3.1 Market Drivers and Impact Analysis
3.2 Market Restraints and Impact Analysis
3.3 Market Opportunities and Impact Analysis
3.3.1 Expanding TAVR Indications
3.3.2 Structural Heart Innovation
3.3.3 Outpatient & Ambulatory Expansion
3.4 Patent & Innovation Analysis (2020–2025)
(What this section provides: Examines growth catalysts, reimbursement landscape, innovation momentum, and regulatory shifts influencing the US structural heart ecosystem.)
4. US Transcatheter Heart Valve Devices Market: Market Environment & Industry
4.1 PESTEL Analysis
4.1.1 Political
4.1.2 Economic
4.1.3 Social
4.1.4 Technological
4.1.5 Environmental
4.1.6 Legal
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Buyers
4.2.3 Bargaining Power of Suppliers
4.2.4 Substitution Risk
4.2.5 Competitive Rivalry
4.3 Pricing Trend Analysis by Region (2024–2030)
4.4 Value Chain & Supply Chain Analysis
4.5 Procedure & Innovation Landscape
4.6 Regulatory Framework Analysis (FDA & CMS)
4.7 Import/Export Restrictions & Tariff Impact
4.8 Government Initiatives & Reimbursement Landscape
4.9 Impact of Geopolitical & Supply Chain Disruptions
(What this section provides: Presents macroeconomic, regulatory, pricing, competitive, and technological forces shaping the US Transcatheter Heart Valve Devices industry.)
5. US Transcatheter Heart Valve Devices Market – By Product Type
5.1 Overview
5.2 Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.2.1 Transcatheter Aortic Valve Replacement (TAVR)
5.2.2 Transcatheter Mitral Valve Repair & Replacement (TMVR)
5.2.3 Transcatheter Pulmonary Valve Replacement (TPVR)
5.2.4 Transcatheter Tricuspid Valve Repair & Replacement
(What this section provides: Analyzes revenue contribution and long-term growth prospects of each valve category across US hospitals and cardiac centers.)
6. US Transcatheter Heart Valve Devices Market – By Material
6.1 Overview
6.2 Segment Share Analysis, By Material, 2025 & 2035 (%)
6.2.1 Biological Tissue Valves
6.2.2 Mechanical Valves
6.2.3 Hybrid & Polymer-Based Valves
(What this section provides: Evaluates durability, innovation trends, and material preferences influencing adoption across US cardiology practices.)
7. US Transcatheter Heart Valve Devices Market – By Procedure Approach
7.1 Overview
7.2 Segment Share Analysis, By Procedure Approach, 2025 & 2035 (%)
7.2.1 Transfemoral
7.2.2 Transapical
7.2.3 Transaortic
7.2.4 Transsubclavian/Transaxillary
(What this section provides: Assesses procedural trends and minimally invasive approach adoption across US healthcare facilities.)
8. US Transcatheter Heart Valve Devices Market – By End-User
8.1 Overview
8.2 Segment Share Analysis, By End-User, 2025 & 2035 (%)
8.2.1 Hospitals
8.2.2 Cardiac Catheterization Laboratories
8.2.3 Ambulatory Surgical Centers
(What this section provides: Identifies demand concentration across care delivery settings and expansion into outpatient structural heart programs.)
9. US Transcatheter Heart Valve Devices Market – By Geography
9.1 Introduction
9.2 Segment Share Analysis, By Geography, 2025 & 2035 (%)
9.3 West Region
9.3.1 Regional Overview & Trends
9.3.2 Key Manufacturers in West Region
9.3.3 Market Size and Forecast by State (2025–2035)
9.3.3.1 California
9.3.3.2 Washington
9.3.3.3 Colorado
9.3.3.4 Arizona
9.3.3.5 Oregon
9.3.3.6 Utah
9.3.3.7 Nevada
9.3.3.8 New Mexico
9.3.3.9 Idaho
9.3.3.10 Montana
9.3.3.11 Wyoming
9.3.3.12 Alaska
9.3.3.13 Hawaii
9.4 Northeast Region
9.4.1 Regional Overview & Trends
9.4.2 Market Size and Forecast by State (2025–2035)
9.4.2.1 New York
9.4.2.2 Massachusetts
9.4.2.3 New Jersey
9.4.2.4 Pennsylvania
9.4.2.5 Connecticut
9.4.2.6 Maine
9.4.2.7 Vermont
9.4.2.8 New Hampshire
9.4.2.9 Rhode Island
9.4.2.10 Delaware
9.5 South Region
9.5.1 Regional Overview & Trends
9.5.2 Market Size and Forecast by State (2025–2035)
9.5.2.1 Texas
9.5.2.2 Florida
9.5.2.3 Georgia
9.5.2.4 North Carolina
9.5.2.5 Tennessee
9.5.2.6 South Carolina
9.5.2.7 Alabama
9.5.2.8 Mississippi
9.5.2.9 Louisiana
9.5.2.10 Arkansas
9.5.2.11 Kentucky
9.5.2.12 Oklahoma
9.5.2.13 Maryland
9.5.2.14 Virginia
9.5.2.15 West Virginia
9.6 Midwest Region
9.6.1 Regional Overview & Trends
9.6.2 Market Size and Forecast by State (2025–2035)
9.6.2.1 Illinois
9.6.2.2 Ohio
9.6.2.3 Michigan
9.6.2.4 Minnesota
9.6.2.5 Indiana
9.6.2.6 Wisconsin
9.6.2.7 Missouri
9.6.2.8 Iowa
9.6.2.9 Kansas
9.6.2.10 Nebraska
9.6.2.11 North Dakota
9.6.2.12 South Dakota
(What this section provides: Detailed state-level revenue forecasts, procedural density, reimbursement penetration, and regional growth hotspots across all US regions.)
10. US Transcatheter Heart Valve Devices Market: Competitive Landscape & Company Profiles
10.1 Market Share Analysis (2025)
10.2 Company Positioning Matrix
10.3 Company Profiles
10.3.1 Edwards Lifesciences
10.3.2 Medtronic
10.3.3 Abbott Laboratories
10.3.4 Boston Scientific Corporation
10.3.5 JenaValve Technology
10.3.6 LivaNova PLC
10.3.7 Artivion (CryoLife)
10.3.8 Anteris Technologies
10.3.9 Colibri Heart Valve
10.3.10 HighLife SAS
10.3.11 Cardiovalve Ltd.
10.3.12 Venus Medtech (US Operations)
10.3.13 Meril Life Sciences (US Presence)
10.3.14 Pi-Cardia
10.3.15 VDyne
10.3.16 Shockwave Medical
10.3.17 Ancora Heart
10.3.18 4C Medical Technologies
10.3.19 Foldax Inc.
10.3.20 Micro Interventional Devices
10.3.21 Peijia Medical (US Clinical Programs)
10.3.22 Lepu Medical (US Distribution)
10.3.23 MedAlliance
10.3.24 Transcatheter Technologies GmbH
10.3.25 Neovasc
(What this section provides: Competitive benchmarking, strategic positioning, innovation pipeline comparison, and US market share insights.)
11. US Transcatheter Heart Valve Devices Market: Future Market Outlook (2025–2035)
11.1 Scenario Analysis (Optimistic, Realistic, Pessimistic)
11.2 Expansion to Low-Risk & Younger Populations
11.3 Outpatient Structural Heart Programs
11.4 AI-Integrated Imaging & Robotics
11.5 M&A and Investment Trends
(What this section provides: Long-term market trajectory analysis, disruptive trends, and strategic growth themes.)
12. US Transcatheter Heart Valve Devices Market: Strategic Recommendations
(What this section provides: Actionable recommendations for manufacturers, investors, healthcare systems, and distributors operating in the US structural heart ecosystem.)
13. US Transcatheter Heart Valve Devices Market: Disclaimer
(What this section provides: Legal limitations, usage conditions, and methodological boundaries of the report.)
List of Tables
TABLE 1: List of Data Sources
TABLE 2: Market Drivers; Impact Analysis
TABLE 3: Market Restraints; Impact Analysis
TABLE 4: US Transcatheter Heart Valve Devices Market: Product Type Snapshot (2025)
TABLE 5: Segment Dashboard; Definition and Scope, by Product Type
TABLE 6: US Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 7: US Transcatheter Heart Valve Devices Market: Material Snapshot (2025)
TABLE 8: Segment Dashboard; Definition and Scope, by Material
TABLE 9: US Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 10: US Transcatheter Heart Valve Devices Market: Procedure Approach Snapshot (2025)
TABLE 11: Segment Dashboard; Definition and Scope, by Procedure Approach
TABLE 12: US Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 13: US Transcatheter Heart Valve Devices Market: End-User Snapshot (2025)
TABLE 14: Segment Dashboard; Definition and Scope, by End-User
TABLE 15: US Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 16: US Transcatheter Heart Valve Devices Market: Regional Snapshot (2025)
TABLE 17: Segment Dashboard; Definition and Scope, by Region
TABLE 18: US Transcatheter Heart Valve Devices Market, by Region, 2022–2035 (USD Million)
TABLE 19: California Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 20: California Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 21: California Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 22: California Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 23: Washington Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 24: Washington Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 25: Washington Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 26: Washington Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 27: Colorado Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 28: Colorado Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 29: Colorado Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 30: Colorado Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 31: Arizona Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 32: Arizona Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 33: Arizona Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 34: Arizona Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 35: Oregon Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 36: Oregon Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 37: Oregon Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 38: Oregon Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 39: West – Others Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 40: West – Others Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 41: West – Others Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 42: West – Others Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
(Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, Hawaii)
TABLE 43: New York Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 44: New York Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 45: New York Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 46: New York Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 47: Massachusetts Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 48: Massachusetts Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 49: Massachusetts Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 50: Massachusetts Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 51: New Jersey Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 52: New Jersey Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 53: New Jersey Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 54: New Jersey Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 55: Pennsylvania Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 56: Pennsylvania Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 57: Pennsylvania Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 58: Pennsylvania Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 59: Connecticut Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 60: Connecticut Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 61: Connecticut Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 62: Connecticut Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 63: Northeast – Others Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 64: Northeast – Others Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 65: Northeast – Others Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 66: Northeast – Others Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
(Maine, Vermont, New Hampshire, Rhode Island, Delaware)
TABLE 67: Texas Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 68: Texas Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 69: Texas Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 70: Texas Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 71: Florida Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 72: Florida Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 73: Florida Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 74: Florida Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 75: Georgia Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 76: Georgia Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 77: Georgia Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 78: Georgia Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 79: North Carolina Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 80: North Carolina Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 81: North Carolina Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 82: North Carolina Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 83: Tennessee Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 84: Tennessee Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 85: Tennessee Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 86: Tennessee Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 87: South Carolina Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 88: South Carolina Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 89: South Carolina Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 90: South Carolina Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 91: Alabama Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 92: Alabama Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 93: Alabama Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 94: Alabama Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 95: South – Others Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 96: South – Others Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 97: South – Others Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 98: South – Others Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
(Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, West Virginia)
TABLE 99: Illinois Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 100: Illinois Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 101: Illinois Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 102: Illinois Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 103: Ohio Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 104: Ohio Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 105: Ohio Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 106: Ohio Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 107: Michigan Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 108: Michigan Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 109: Michigan Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 110: Michigan Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 111: Minnesota Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 112: Minnesota Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 113: Minnesota Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 114: Minnesota Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 115: Indiana Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 116: Indiana Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 117: Indiana Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 118: Indiana Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 119: Wisconsin Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 120: Wisconsin Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 121: Wisconsin Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 122: Wisconsin Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 123: Missouri Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 124: Missouri Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 125: Missouri Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 126: Missouri Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 127: Midwest – Others Transcatheter Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 128: Midwest – Others Transcatheter Heart Valve Devices Market, by Material, 2022–2035 (USD Million)
TABLE 129: Midwest – Others Transcatheter Heart Valve Devices Market, by Procedure Approach, 2022–2035 (USD Million)
TABLE 130: Midwest – Others Transcatheter Heart Valve Devices Market, by End-User, 2022–2035 (USD Million)
(Iowa, Kansas, Nebraska, North Dakota, South Dakota)
List of Figures
FIGURE 1: US Transcatheter Heart Valve Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: PESTLE Analysis
FIGURE 5: Porter’s Five Forces Analysis
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: Market Dynamics
FIGURE 8: Innovation & Patent Landscape (2020–2024)
FIGURE 9: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 10: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 11: Product Type Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 12: Material Segment Market Share Analysis, 2025 & 2035
FIGURE 13: Material Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 14: Procedure Approach Segment Market Share Analysis, 2025 & 2035
FIGURE 15: Procedure Approach Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 16: End-User Segment Market Share Analysis, 2025 & 2035
FIGURE 17: End-User Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 18: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Regional Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 20: West Region US Transcatheter Heart Valve Devices Market Share and Leading Players, 2025
FIGURE 21: Northeast Region US Transcatheter Heart Valve Devices Market Share and Leading Players, 2025
FIGURE 22: South Region US Transcatheter Heart Valve Devices Market Share and Leading Players, 2025
FIGURE 23: Midwest Region US Transcatheter Heart Valve Devices Market Share and Leading Players, 2025
FIGURE 24: West Region Market Share Analysis by State, 2025
FIGURE 25: California Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 26: Washington Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 27: Colorado Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 28: Arizona Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 29: Oregon Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 30: Others (West Region) Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 31: South Region Market Share Analysis by State, 2025
FIGURE 32: Texas Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 33: Florida Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 34: Georgia Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 35: North Carolina Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 36: Tennessee Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 37: South Carolina Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 38: Alabama Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 39: Others (South Region) Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 40: Midwest Region Market Share Analysis by State, 2025
FIGURE 41: Illinois Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 42: Ohio Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 43: Michigan Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 44: Minnesota Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 45: Indiana Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 46: Wisconsin Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 47: Missouri Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 48: Others (Midwest Region) Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 49: Northeast Region Market Share Analysis by State, 2025
FIGURE 50: New York Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 51: Massachusetts Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 52: New Jersey Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 53: Pennsylvania Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 54: Connecticut Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 55: Others (Northeast Region) Transcatheter Heart Valve Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
